FDA Issues Guidance on Drug & Biological Product Promotional Labeling
The Food and Drug Administration (FDA) is announcing the availability of a guidance document entitled "Product Name Placement, Size, and Prominence in Advertising and Promotional Labeling." The guidance is intended to clarify for applicants the requirements for product name placement,…
Sign up for a free preview to unlock the rest of this article
Export Compliance Daily combines U.S. export control news, foreign border import regulation and policy developments into a single daily information service that reliably informs its trade professional readers about important current issues affecting their operations.
size, prominence, and frequency in promotional labeling and advertising for prescription human and animal drugs and biological products. This guidance finalizes the draft guidance published in January 1999. Comments may be submitted at any time.